Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.
about
Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic reviewMouse Models in Prostate Cancer Translational Research: From Xenograft to PDXT-cell receptor gene therapy--ready to go viral?Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Normal and malignant muscle cell transplantation into immune compromised adult zebrafish.Mouse Tumor Biology (MTB): a database of mouse models for human cancerSpontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesFunctional expression of sodium-glucose transporters in cancer.XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancerCCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.CAR T-cell therapy: toxicity and the relevance of preclinical models.Chimeric antigen receptor T cells for the treatment of cancer and the future of preclinical models for predicting their toxicities.Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.Development of Humanized Mice in the Age of Genome Editing.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo.Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.Anti-human SIRPα antibody is a new tool for cancer immunotherapy.Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.
P2860
Q26741651-11303C8A-7608-4F60-823D-B632FDDD053AQ26746524-EA0E208D-AB10-4843-9611-1053D9D66F3AQ28081611-BE7D4BF7-FEEF-495F-936E-7455700D5B31Q33440718-CFE408B2-092A-4B20-8508-0360D27B8709Q33815087-867C9DD6-0EB5-4B90-AB2D-ABA65501335AQ35161809-98957B49-2DAB-4BED-9506-2AE45F2A0A23Q35254961-5FD60967-1EA5-4F07-957D-98FCF2C99FDCQ35634016-83E1F616-10ED-4553-9CD4-02D3296338BFQ35738486-79086192-D14D-434A-A898-06C80911954DQ35909986-585FA0E6-4E22-45B4-9970-6FD1CA94D3B4Q36185583-965BBFCA-83A9-422E-A0FF-380A62A15D21Q37655544-D196CBAB-4881-4AC3-AFB4-BD82B19C5C16Q38245928-759C48C0-E3FD-4FBD-9668-2756DB18560DQ38525018-A1F4F9D1-0D6C-41FC-93B2-8E3E99F3A6CEQ38666256-848E79BB-2B62-4766-A1AB-22F556389E7FQ38735015-AC0C8F11-BC1C-4D1F-8EB6-7140E80AB3BFQ38800999-BC17232E-EF26-4044-B326-DCF64782F30FQ38884521-CAD0498B-3E93-4FE9-BBD4-93340C4901A5Q39057246-4EACF93C-E6F3-486C-912C-D80B75B2CCCEQ40716797-C530D896-0E7F-468B-B06E-8140EBD2C264Q42040539-59847CB2-39DF-4200-9D15-6B87C98F24AFQ47843897-6AE6AF0D-DDA5-4CC9-9D1A-17412F796965Q51763013-D6C4BCB9-3C2E-4171-BBF4-D465AD7D3C26Q52688875-54EDAC8A-4AEC-43B0-B4E1-36ADD7EB728DQ54204985-8DE819B1-E1E8-4947-BA7E-DB9B91521143Q55380373-182F9B13-53D6-49F9-817E-1066856EB7EB
P2860
Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Humanized NOD-SCID IL2rg–/– mi ...... dividualized cancer therapies.
@en
type
label
Humanized NOD-SCID IL2rg–/– mi ...... dividualized cancer therapies.
@en
prefLabel
Humanized NOD-SCID IL2rg–/– mi ...... dividualized cancer therapies.
@en
P2093
P1433
P1476
Humanized NOD-SCID IL2rg–/– mi ...... ndividualized cancer therapies
@en
P2093
John Facciponte
Qianjun Zhou
P356
10.1016/J.CANLET.2013.10.015
P407
P50
P577
2014-03-01T00:00:00Z